Thrivent Financial for Lutherans
MRNA icon

Thrivent Financial for Lutherans’s Moderna MRNA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Buy
30,477
+17,288
+131% +$807K ﹤0.01% 1615
2025
Q4 		$389K Sell
13,189
-152
-1% -$4.13K ﹤0.01% 2339
2025
Q3 		$345K Sell
13,341
-79,658
-86% -$2.22M ﹤0.01% 2195
2025
Q2 		$2.57M Buy
92,999
+79,726
+601% +$2.1M 0.01% 1188
2025
Q1 		$376K Sell
13,273
-12,261
-48% -$435K ﹤0.01% 2167
2024
Q4 		$1.06M Buy
25,534
+3
+0% +$143 ﹤0.01% 1861
2024
Q3 		$1.71M Sell
25,531
-180
-0.7% -$16.5K ﹤0.01% 1554
2024
Q2 		$3.05M Sell
25,711
-73
-0.3% -$9.24K 0.01% 1119
2024
Q1 		$2.75M Buy
25,784
+11,992
+87% +$1.21M 0.01% 1189
2023
Q4 		$1.37M Sell
13,792
-126
-0.9% -$10.6K ﹤0.01% 1641
2023
Q3 		$1.44M Sell
13,918
-15,011
-52% -$1.67M ﹤0.01% 1526
2023
Q2 		$3.52M Sell
28,929
-1,042
-3% -$139K 0.01% 1003
2023
Q1 		$4.59M Buy
29,971
+12,359
+70% +$2.04M 0.01% 845
2022
Q4 		$3.16M Buy
17,612
+1,471
+9% +$241K 0.01% 984
2022
Q3 		$1.91M Sell
16,141
-314
-2% -$47.6K 0.01% 1248
2022
Q2 		$2.35M Buy
16,455
+178
+1% +$25.4K 0.01% 1140
2022
Q1 		$2.8M Sell
16,277
-9,248
-36% -$1.56M 0.01% 1132
2021
Q4 		$6.43M Sell
25,525
-19,483
-43% -$5.7M 0.01% 815
2021
Q3 		$17.3M Sell
45,008
-9,270
-17% -$3.42M 0.04% 508
2021
Q2 		$12.8M Buy
54,278
+1,516
+3% +$271K 0.03% 612
2021
Q1 		$6.91M Buy
52,762
+47,347
+874% +$6.86M 0.02% 789
2020
Q4 		$566K Buy
+5,415
New +$548K ﹤0.01% 2078

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Thrivent Financial for Lutherans's MRNA Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its Moderna (MRNA) stake by 131% in Q1 2026, buying an estimated $807K and bringing the position to 30,477 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1615.

Thrivent Financial for Lutherans first reported a position in MRNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $17.3M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Thrivent Financial for Lutherans held 30,477 shares of Moderna worth $1.55M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 17,288 Moderna shares in Q1 2026, an estimated $807K.
  • Moderna made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1615 holding.
  • Thrivent Financial for Lutherans first reported a position in Moderna in Q4 2020 and has held it in 22 quarters since.
  • Thrivent Financial for Lutherans's Moderna position peaked at $17.3M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.